In conclusion, we built up a three-m6A methylation regulators-based RS of METTL3, METTL14 and HNRNPA2B1 that may become potential biomarker for prognosis prediction of clear cell renal cell carcinoma patients, our results call for further experimental studies for validations. Here, METTL3 is linked to clear cell renal carcinoma.